$BNTC

$8.68 +$0.09 (1.05%) Close

$BNTC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Ownership

13F as of Q2 2026 · 34.9M shares outstanding

Who owns BNTC?

By type of holder

Institutions 95.0% Insiders 0.4% Everyone else 4.6%

Concentration Top 10 holders own 120.6%

Averill Master Fund, Ltd. 43.7% · Montanova Capital, LLC 33.1%

Institutional ownership

95.0%

+1.9 pts vs last qtr

Institutional holders

-2 vs last qtr

Net shares bought

+655.8K

by institutions in Q2 2026

New / sold out

11 / 13

positions opened vs closed

How is ownership changing?

Institutions, last 8 quarters

Biggest buyers in Q2 2026

Jupiter Topco LLC NEW +2.5M
Simplify Asset Management Inc. +443.3K

Biggest sellers in Q2 2026

Janus Henderson Group PLC SOLD OUT −2.9M
Longaeva Partners L.P. −110.1K

Who is planning to sell?

No insider has filed a notice of proposed sale (Form 144) for Benitec Biopharma Inc in the last 12 months.

Is your stake being diluted?

Diluted share count, FY2024–FY2026

+153.5%

+59.22% a year

Each share's claim on the business

−60.6%

shrank without buying or selling a share

Spent on buybacks vs paid in stock

— vs $44.7M

over 3 fiscal years

Diluted shares, split-adjusted

Buybacks Stock-based comp

How patient are the owners?

Institutional shares by how long they've been held

5+ years0% 3–5 years0% 1–3 years78% Under 1 year22%

Quarterly turnover

11.4%

of institutional shares changed hands

Top 10 managers, median time held

2 years

Super Investors

Investment managers reporting BNTC on Form 13F

Holder	Shares	% of company	Change vs last qtr	Held since	% of their book
MC Montanova Capital, LLC 13D · 44.1%	11.5M	33.11%	Unchanged	2023	2.8%
Shares held by quarter Peak holding11.5M (Q4'25) Change over 8 quarters+2.7M Share of the company33.110% Disclosed stake13D · 44.1% Montanova Capital, LLC's full portfolio →
JH Janus Henderson Group PLC	—	—	SOLD OUT	—	0.0%
Shares held by quarter Peak holding2.9M (Q1'25) Change over 8 quarters−876.5K Janus Henderson Group PLC's full portfolio →

Montanova Capital, LLC

13D · 44.1%

11.5M

% of company

33.11%

Change vs last qtr

Unchanged

Held since

2023

Janus Henderson Group PLC

—

% of company

—

Change vs last qtr

SOLD OUT

Held since

—

28 more super investors behind a free account

See every manager holding Benitec Biopharma Inc, how their position has changed, and how long they've held it.

Institutional Funds

Mutual funds and ETFs reporting BNTC on Form N-PORT; together they hold 14.6% of the company

Fund	Position value	Shares	% of company	% of the fund	As of
SH Simplify Health Care ETF Simplify Exchange Traded Funds	$13.5M	1.0M	2.88%	3.75%	June 30, 2026
FB Franklin Biotechnology Discovery Fund Franklin Strategic Series	$11.7M	995.2K	2.85%	1.01%	July 31, 2026

Simplify Health Care ETF

Simplify Exchange Traded Funds

Position value

$13.5M

% of company

2.88%

% of the fund

3.75%

As of

June 30, 2026

Franklin Biotechnology Discovery Fund

Franklin Strategic Series

Position value

$11.7M

% of company

2.85%

% of the fund

1.01%

As of

July 31, 2026

23 more funds behind a free account

See every fund holding Benitec Biopharma Inc and how much of the fund the position is.

Insiders and 5%+ holders

From Forms 3/4/5 and Schedules 13D/G

Holder	Shares	% of company	Change vs last qtr	8 quarters	Held since	% of their book
AM Averill Master Fund, Ltd. 5%+ holder 13D · 37.8%	15.2M	43.68%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company43.680% Disclosed stake13D · 37.8% View the 13D/G filing →
AM Averill Madison Master Fund, Ltd. 5%+ holder 13D · 6.3%	2.5M	7.24%	—	—	—	—
This holder reports through Schedule 13D/G, not a quarterly 13F. Share of the company7.240% Disclosed stake13D · 6.3% View the 13D/G filing →

Averill Master Fund, Ltd.

5%+ holder13D · 37.8%

15.2M

% of company

43.68%

Change vs last qtr

—

Held since

—

Averill Madison Master Fund, Ltd.

5%+ holder13D · 6.3%

2.5M

% of company

7.24%

Change vs last qtr

—

Held since

—

1 more holders behind a free account

See every insider and 5%+ holder of Benitec Biopharma Inc.

Comments